Wasfy Jason H, Zigler Corwin Matthew, Choirat Christine, Wang Yun, Dominici Francesca, Yeh Robert W
From Massachusetts General Hospital, Harvard Medical School, Harvard T.H. Chan School of Public Health, and Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Ann Intern Med. 2017 Mar 7;166(5):324-331. doi: 10.7326/M16-0185. Epub 2016 Dec 27.
Whether hospitals with the highest risk-standardized readmission rates (RSRRs) subsequently experienced the greatest improvement after passage of the Medicare Hospital Readmissions Reduction Program (HRRP) is unknown.
To evaluate whether passage of the HRRP was followed by acceleration in improvement in 30-day RSRRs after hospitalizations for acute myocardial infarction (AMI), congestive heart failure (CHF), or pneumonia and whether the lowest-performing hospitals had faster acceleration in improvement after passage of the law than hospitals that were already performing well.
Pre-post analysis stratified by hospital performance groups.
U.S. acute care hospitals.
15 170 008 Medicare patients discharged alive from 2000 to 2013.
Passage of the HRRP.
30-day readmission rates after hospitalization for AMI, CHF, or pneumonia for hospitals in the highest-performance (0% penalty), average-performance (>0% and <0.50% penalty), low-performance (≥0.50% and <0.99% penalty), and lowest-performance (≥0.99% penalty) groups.
Of 2868 hospitals serving 1 109 530 Medicare discharges annually, 30.1% were highest performers, 44.0% were average performers, 16.8% were low performers, and 9.0% were lowest performers. After controlling for prelaw trends, an additional 67.6 (95% CI, 66.6 to 68.4), 74.8 (CI, 74.0 to 75.4), 85.4 (CI, 84.0 to 86.8), and 95.1 (CI, 92.6 to 97.5) readmissions per 10 000 discharges were found to have been averted per year in the highest-, average-, low-, and lowest-performance groups, respectively, after passage of the law.
Inability to distinguish between improvement caused by the magnitude of the penalty or by different levels of health improvement in different patient populations.
After passage of the HRRP, 30-day RSRRs for myocardial infarction, heart failure, and pneumonia decreased more rapidly than before the law's passage. Improvement was most marked for hospitals with the lowest prelaw performance.
National Institutes of Health.
在医疗保险医院再入院率降低计划(HRRP)通过后,具有最高风险标准化再入院率(RSRR)的医院随后是否经历了最大程度的改善尚不清楚。
评估HRRP通过后,急性心肌梗死(AMI)、充血性心力衰竭(CHF)或肺炎住院后30天RSRR的改善是否加速,以及表现最差的医院在该法律通过后改善加速是否比原本表现良好的医院更快。
按医院绩效组分层的前后分析。
美国急性护理医院。
2000年至2013年存活出院的15170008名医疗保险患者。
HRRP的通过。
最高绩效(0%罚款)、平均绩效(>0%且<0.50%罚款)、低绩效(≥0.50%且<0.99%罚款)和最低绩效(≥0.99%罚款)组中,AMI、CHF或肺炎住院后30天的再入院率。
在每年为1109530名医疗保险出院患者服务的2868家医院中,30.1%为最高绩效医院,44.0%为平均绩效医院,16.8%为低绩效医院,9.0%为最低绩效医院。在控制法律通过前的趋势后,发现法律通过后,最高、平均、低和最低绩效组每年每10000例出院患者分别避免了67.6(95%CI,66.6至68.4)、74.8(CI,74.0至75.4)、85.4(CI,84.0至86.8)和95.1(CI,92.6至97.5)例再入院。
无法区分罚款幅度导致的改善与不同患者群体中不同健康改善水平导致的改善。
HRRP通过后,心肌梗死、心力衰竭和肺炎的30天RSRR下降速度比法律通过前更快。法律通过前表现最差的医院改善最为明显。
美国国立卫生研究院。